International Journal of Gynecological Cancer

Clinical application of oxaliplatin in epithelial ovarian cancer
pp. 1717-1732(16)
Authors: FU,; KAVANAGH,; HU,; BAST,

Identification of genes associated with ovarian cancer metastasis using microarray expression analysis
pp. 1733-1745(13)
Authors: LANCASTER,; DRESSMAN,; CLARKE,; SAYER,; MARTINO,; CRAGUN,; HENRIOTT,; GRAY,; SUTPHEN,; ELAHI,; WHITAKER,; WEST,; MARKS,; NEVINS,; BERCHUCK,

Mode of detection of recurrent gynecological malignancy: does routine follow-up delay diagnosis and treatment?
pp. 1746-1748(3)
Author: NORDIN,

Measurement of vaginal length: reliability of the vaginal sound—a Gynecologic Oncology Group Study
pp. 1749-1755(7)
Authors: BRUNER,; NOLTE,; SHAHIN,; HUANG,; SOBEL,; GALLUP,; CELLA,

Ovarian cancer—can intraperitoneal therapy be regarded as new standard in Germany?
pp. 1756-1760(5)
Authors: DUBOIS,; SCHMALFELDT,; MEIER,; SEHOULI,; PFISTERER,

Intraperitoneal chemotherapy for advanced epithelial ovarian cancer: a Canadian perspective
pp. 1761-1765(5)
Authors: ALHAYKI,; HOPKINS,; LE,; FUNG KEE FUNG,

Outcomes of gynecologic oncology patients admitted to the intensive care unit following surgery: a university teaching hospital experience
pp. 1766-1769(4)
Authors: LEATH,; KENDRICK,; NUMNUM,; STRAUGHN,; ROCCONI,; SFAKIANOS,; LANG,

Survival in ovarian cancer in Wales: prior to introduction of all Wales guidelines
pp. 1770-1776(7)
Authors: SHYLASREE,; HOWELLS,; LIM,; JONES,; FIANDER,; ADAMS,; EVANS,

Inhibition of nuclear factor-κB by an antioxidant enhances paclitaxel sensitivity in ovarian carcinoma cell line
pp. 1777-1782(6)
Authors: LIU,; WANG,; KONG,

Expression of aminopeptidase N/CD13 in human ovarian cancers
pp. 1783-1788(6)
Authors: SUROWIAK,; DRĄG,; MATERNA,; SUCHOCKI,; GRZYWA,; SPACZYŃSKI,; DIETEL,; OLEKSYSZYN,; ZABEL,; LAGE,

The prognostic value of endoglin (CD105) expression in ovarian carcinoma
pp. 1789-1793(5)
Authors: TASKIRAN,; ERDEM,; ONAN,; ARISOY,; ACAR,; VURAL,; ATAOGLU,; GUNER,

Expression of matrix metalloproteinase-26 and tissue inhibitors of metalloproteinase-3 and -4 in normal ovary and ovarian carcinoma
pp. 1794-1800(7)
Authors: RIPLEY,; TUNUGUNTLA,; SUSI,; CHEGINI,

The distribution and differential risks of human papillomavirus genotypes in cervical preinvasive lesions: a Taiwan Cooperative Oncologic Group Study
pp. 1801-1808(8)
Authors: CHEN,; LIU,; CHOU,; HO,; TWU,; KAN,; CHUANG,; CHU,; HSIEH,

Human papillomavirus type 18 and other risk factors for cervical cancer in Jakarta, Indonesia
pp. 1809-1814(6)
Authors: deBOER,; VET,; AZIZ,; CORNAIN,; PURWOTO,; van denAKKER,; DIJKMAN,; PETERS,; FLEUREN,

Optical coherence tomography as a diagnostic aid to visual inspection and colposcopy for preinvasive and invasive cancer of the uterine cervix
pp. 1815-1822(8)
Authors: ESCOBAR,; ROJAS-ESPAILLAT,; TISCI,; ENERSON,; BRAINARD,; SMITH,; TRESSER,; FELDCHTEIN,; ROJAS,; BELINSON,

The use of electrical impedance spectroscopy in the detection of cervical intraepithelial neoplasia
pp. 1823-1832(10)
Authors: ABDUL,; BROWN,; MILNES,; TIDY,

Cervical cancer incidence and survival in Korea: 1993-2002
pp. 1833-1838(6)
Authors: CHUNG,; JANG,; JUNG,; WON,; SHIN,; KIM,; LEE,

Pattern of failure and long-term morbidity in patients undergoing postoperative radiotherapy for cervical cancer
pp. 1839-1845(7)
Authors: JAIN,; HUNTER,; LIVSEY,; COYLE,; KITCHENER,; SWINDELL,; DAVIDSON,

Impact of hemoglobin on survival of cervical carcinoma patients treated with concurrent chemoradiotherapy is dependent on lymph node metastasis findings by magnetic resonance imaging
pp. 1846-1854(9)
Authors: CHOI,; YI,; SIN,; YE,; SHIN,; LEE,

Erythropoietin administration during primary treatment for locally advanced cervical carcinoma is associated with poor response to radiation
pp. 1855-1861(7)
Authors: TEMKIN,; HELLMANN,; SERUR,; LEE,; ABULAFIA,

Methylation status of the fragile histidine triad and E-cadherin genes in plasma of cervical cancer patients
pp. 1862-1867(6)
Authors: REN,; MIAO,; YANG,; ZHAO,; SUN,; SONG,

Involvement of tumor suppressor in lung cancer 1 gene expression in cervical carcinogenesis
pp. 1868-1872(5)
Authors: YANG,; WANG,; XIA,

Implication of human telomerase reverse transcriptase in cervical carcinogenesis and cancer recurrence
pp. 1873-1879(7)
Authors: WANG,; KO,

Lymph node size in uterine cancer: a revisit
pp. 1880-1884(5)
Authors: TANGJITGAMOL,; MANUSIRIVITHAYA,; JESADAPATARAKUL,; LEELAHAKORN,; THAWARAMARA,

Role of lymphadenectomy and pelvic radiotherapy in patients with clinical FIGO stage I endometrial adenocarcinoma: an analysis of 208 patients
pp. 1885-1893(9)
Authors: KALOGIANNIDIS,; LAMBRECHTS,; AMANT,; NEVEN,; VAN LIMBERGEN,; VERGOTE,

Uterine metastasis from hepatocellular carcinoma: a case report
pp. 1894-1896(3)
Authors: RYO,; SATO,; TAKESHITA,; AYABE,; TANAKA,

HER-2/neu overexpression in uterine papillary serous cancers and its possible therapeutic implications
pp. 1897-1902(6)
Authors: VILLELLA,; COHEN,; SMITH,; HIBSHOOSH,; HERSHMAN,

Immunohistochemical characterization of cancer antigen in uterine cancers
pp. 1903-1910(8)
Authors: NUR,; CHUANG,; RAMASWAMY,

Endometrial tumor invasiveness is related to metalloproteinase 2 and tissue inhibitor of metalloproteinase 2 expressions
pp. 1911-1917(7)
Authors: GRAESSLIN,; CORTEZ,; UZAN,; BIREMBAUT,; QUEREUX,; DARAÏ,

Estrogen and progesterone receptors and telomerase enzyme immunohistochemical detection in gestational trophoblastic tumors
pp. 1918-1926(9)
Authors: EL-SHALAKANY,; KAMEL,; ISMAIL,; SALAH,; EL-DEEN FAHMY,; EL-DEEN AMMAR,

Laparoscopically assisted radical vaginal hysterectomy (Coelio-Schauta): a comparison with open Wertheim/Meigs hysterectomy
pp. 1927-1932(6)
Authors: SHARMA,; BAILEY,; ANDERSON,; MURDOCH,

Laparoscopic splenectomy for isolated parenchymal splenic metastasis of ovarian cancer
pp. 1933-1935(3)
Authors: OTROCK,; SEOUD,; KHALIFEH,; MAKAREM,; SHAMSEDDINE,

Severe prolonged gastroparesis after cytoreductive surgery in an advanced ovarian cancer patient
pp. 1936-1939(4)
Authors: CAPRINO,; FAGOTTI,; MISSERE,; FANFANI,; SCAMBIA,

A substantial part of the fallopian tube is left after standard prophylactic bilateral salpingo-oophorectomy
pp. 1940-1944(5)
Authors: GERRITZEN,; GREFTE,; HOOGERBRUGGE,; BULTEN,; MASSUGER,; deHULLU,

Recurrent small cell carcinoma of the ovary treated with docetaxel: a case report
pp. 1944-1946(3)
Authors: NIIMI,; KIYOKAWA,; TAKAKURA,; OCHIAI,; TANAKA,

Triple simultaneous primary gynecological malignancies in a 56-year-old patient
pp. 1947-1950(4)
Authors: IŞIN DOĞAN EKICI,; KÜÇÜKALI,; COŞKUN SALMAN,; AYHAN,

Methodology in plasma proteomic pattern experiments
pp. 1951-1952(2)

Response to letter to the Editor
pp. 1953-1953(1)

To the Editor:
pp. 1954-1955(2)